PEGAVISION CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 509 TWD | +0.59% |
|
+3.88% | +28.37% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 7.58B 235M | Sales 2025 * | 8.79B 273M | Capitalization | 39.7B 1.23B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.17B 67.29M | Net income 2025 * | 2.56B 79.37M | EV / Sales 2024 * | 4.38 x |
| Net cash position 2024 * | 6.5B 202M | Net cash position 2025 * | 8.51B 264M | EV / Sales 2025 * | 3.55 x |
| P/E ratio 2024 * |
18.3
x | P/E ratio 2025 * |
16.2
x | Employees | - |
| Yield 2024 * |
2.45% | Yield 2025 * |
2.65% | Free-Float | 52.23% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.59% | ||
| 1 week | +3.88% | ||
| Current month | -2.86% | ||
| 1 month | +11.01% | ||
| 3 months | +32.21% | ||
| 6 months | +27.89% | ||
| Current year | +28.37% |
1 week
489.50
522.00
1 month
446.50548.00
Current year
368.00548.00
1 year
328.00548.00
3 years
270.50678.00
5 years
81.50678.00
10 years
63.71678.00
| Managers | Title | Age | Since |
|---|---|---|---|
Te Sheng Yang
CEO | Chief Executive Officer | - | 18-06-13 |
| Director of Finance/CFO | - | 13-12-26 | |
Danny Peng
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tzu Hsien Tung
BRD | Director/Board Member | 63 | 09-08-11 |
Te Sheng Yang
CEO | Chief Executive Officer | - | 18-06-13 |
Ming Tung Kuo
CHM | Chairman | - | 09-08-11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 112 M€ | +5.51% | - | |
| 0.00% | 34 M€ | +4.26% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 509 | +0.59% | 420,346 |
| 24-05-15 | 506 | -1.17% | 544,610 |
| 24-05-14 | 512 | +2.40% | 619,131 |
| 24-05-13 | 500 | +1.21% | 639,292 |
| 24-05-10 | 494 | +0.82% | 359,941 |
End-of-day quote Taiwan S.E., May 15, 2024
More quotes
Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-05-23
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
509
TWD
Average target price
529.2
TWD
Spread / Average Target
+3.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +28.37% | 1.23B | |
| +22.30% | 44.19B | |
| +3.48% | 19.46B | |
| -17.76% | 2.31B | |
| +14.54% | 1.92B | |
| -35.09% | 755M | |
| -40.97% | 699M | |
| -7.22% | 677M | |
| +26.26% | 510M | |
| +24.22% | 492M |
- Stock Market
- Equities
- 6491 Stock
